Propanc Biopharma Balance Sheet (2011-2026)

Reported Financials

Propanc Biopharma Quarterly Balance Sheet

Periods 58 quarters

Latest Jun 2026

Propanc Biopharma reported total assets of $12.78M and total liabilities of $3.38M for the quarter ended Jun 2026, down 43.3% year over year. This balance sheet covers 58 quarters of results from Jun 2011 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Jun2026
Accumulated Depreciation	0.02M	0.02M	0.02M	0.03M	0.03M	0.03M	0.02M	0.02M	0.03M	0.02M	0.03M	0.02M	0.03M				0.03M	0.03M	0.03M	0.03M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	0.00M	0.05M	0.07M	0.13M	0.00M	0.02M	0.02M	0.09M	0.01M	0.01M	0.07M	0.01M	0.02M	0.01M	0.01M	0.05M	0.01M	0.60M	0.56M	0.83M
Receivables - OtherOther Receivables
Prepaid Assets		0.01M	0.01M	0.01M	0.01M	0.02M	0.03M		0.01M	0.02M	0.01M	0.00M	0.00M	0.01M	0.00M	9.68M	8.33M	8.14M	7.13M	7.66M
Current Assets	0.01M	0.06M	0.08M	0.14M	0.02M	0.04M	0.05M	0.10M	0.02M	0.15M	0.21M	0.01M	0.03M	0.02M	0.02M	9.74M	8.35M	8.76M	7.71M	8.54M
Non-Current Assets
Property, Plant & Equipment (Net)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	634.00	302.00	160.00	50.00							0.00M	0.00M	0.00M
Long-Term Deferred Tax
Other Non-Current Assets	0.00M	0.00M	0.02M	0.02M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.03M	0.03M	0.05M	12.70M	10.93M	9.14M	7.35M	4.19M
Non-Current Assets	0.01M	0.01M	0.03M	0.02M	0.07M	0.06M	0.05M	0.05M	0.04M	0.03M	0.03M	0.02M	0.05M	0.04M	0.06M	12.79M	11.28M	9.21M	7.40M	4.24M
Assets	0.01M	0.06M	0.11M	0.17M	0.08M	0.09M	0.11M	0.14M	0.06M	0.18M	0.24M	0.04M	0.07M	0.06M	0.08M	22.53M	19.63M	17.98M	15.11M	12.78M
Liabilities
Current Liabilities
Accounts Payables	1.00M	0.83M	0.92M	0.97M	0.94M	0.90M	0.91M	0.92M	0.97M	1.08M	1.16M	1.19M	1.21M	1.24M	1.22M	1.12M	1.49M	1.07M	0.96M	1.13M
Notes Payables							0.07M			0.13M	0.13M	0.13M	0.20M	0.21M	0.17M	0.28M	0.54M
Payables	1.00M	0.83M	0.92M	0.97M	0.94M	0.90M	0.99M	0.92M	0.97M	1.21M	1.29M	1.32M	1.42M	1.45M	1.39M	1.40M	2.03M	1.07M	0.96M	1.13M
Accumulated Expenses	0.08M		0.05M			0.05M	0.02M	0.08M
Other Accumulated Expenses					0.06M		0.06M	0.06M	0.04M	0.05M	0.07M	0.08M	0.09M	0.11M	0.14M	0.17M	0.19M	0.15M	0.17M	0.13M
Short term Debt	0.62M	0.58M	0.97M	1.08M	0.93M	0.91M	0.63M	0.52M	0.39M	0.40M	0.69M	0.58M	0.40M	0.38M	0.41M	0.44M	0.54M	0.11M	0.06M	0.46M
Total Current Liabilities	3.08M	2.37M	3.04M	3.12M	3.06M	2.82M	2.99M	3.06M	3.16M	3.13M	3.76M	3.69M	3.79M	4.10M	4.15M	4.34M	5.58M	3.57M	3.62M	3.35M
Non-Current Liabilities
Non-Current Debt					0.03M		0.05M	0.05M	0.07M	0.03M	0.04M	0.05M	0.06M	0.15M	0.15M	0.09M	0.11M	0.07M	0.07M
Convertible Debt	0.08M	0.08M	0.08M	0.08M	0.08M	0.16M	0.16M	0.12M	0.08M	0.08M	0.14M	0.12M	0.11M	0.15M	0.15M	0.21M	0.29M	0.13M	0.07M
Preferred Stock Liabilities																			1.00M
Operating Leases					0.04M	0.04M	0.03M	0.02M	0.02M	0.01M	0.01M	0.00M					0.04M	0.04M	0.04M	0.02M
Other Non-Current Liabilities	0.05M	0.06M	0.22M	0.06M	0.15M	0.07M	0.01M	0.13M	0.42M	0.12M	0.22M	0.13M	0.13M	0.13M	0.13M	0.19M	0.40M	0.17M	0.32M
Total Non-Current Liabilities	3.03M	2.31M	2.82M	3.06M	0.04M	0.04M	0.03M	0.02M	0.02M	0.04M	0.04M	0.05M	0.06M	0.07M	0.08M	0.09M	0.15M	0.04M	0.04M	0.02M
Total Liabilities	3.08M	2.37M	3.04M	3.12M	3.11M	2.86M	3.02M	3.09M	3.18M	3.17M	3.81M	3.74M	3.85M	4.17M	4.24M	4.44M	5.73M	3.61M	4.66M	3.38M
Shareholder's Equity
Total Debt	0.62M	0.58M	0.97M	1.08M	0.96M	0.91M	0.76M	0.57M	0.46M	0.55M	0.85M	0.76M	0.66M	0.74M	0.72M	0.81M	1.19M	0.17M	0.12M	0.46M
Common Equity	-3.07M	-2.31M	-2.93M	-2.95M	-3.02M	-2.77M	-2.92M	-2.94M	-3.12M	-2.99M	-3.56M	-3.70M	-3.78M	-4.11M	-4.16M	18.09M	13.91M	14.36M	10.45M	9.40M
Liabilities and Shareholders Equity	0.01M	0.06M	0.11M	0.17M	0.08M	0.09M	0.11M	0.14M	0.06M	0.18M	0.24M	0.04M	0.07M	0.06M	0.08M	22.53M	19.63M	17.98M	15.11M	12.78M
Treasury Shares	1.00	1.00	1.00	1.00	0.00	1.00	1.00		0.00
Retained Earnings	-58.20M	-58.80M	-59.70M	-60.40M	-61.56M	-62.56M	-63.07M	-63.88M	-64.68M	-65.18M	-65.80M	-66.34M	-66.70M	-67.05M	-67.48M	-121.55M	-125.62M	-130.46M	-134.48M	-144.48M
Preferred Shares	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M													2.00

Propanc Biopharma Balance Sheet API

Pull Propanc Biopharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PPCB&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "PPCB", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=PPCB&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Propanc Biopharma PPCB Balance Sheet (2011-2026)

Propanc Biopharma Quarterly Balance Sheet

Propanc Biopharma Balance Sheet API

Create an account

Sign In

Reset Password